Table 3:

Median overall survival and progression-free survival by PD-L1 status in ICI pretreated patients

PD-L1 Status	mOS, mo (95% CI)	mOS Hazard Ratio (95% CI)	mPFS, mo	mPFS Hazard Ratio (95% CI)	No.	No. of Refractory Patients	No. of Relapsed Patients
PD-L1 ≥ 50%	5.1 (3.6-not estimable)	1.75 (0.68, 4.54)	2.8 (2.0-not estimable)	1.05 (0.41, 2.67)	9	2	6
PD-L1 ≥ 1%−49%	10.6 (6.7-not estimable)	0.61 (0.18, 1.99)	6.7 (4.5-not estimable)	0.56 (0.17, 1.78)	7	2	3
*PD-L1 < 1%	7.4 (3.3-not estimable)		1.8 (1.0-not estimable)		16	10	3

Abbreviations: 95% CI, 95% confidence interval; mOS, median overall survival; mPFS, median progression-free survival; PD-L1, programmed cell death ligand 1.

^*Reference group for hazard ratio.